Support: 888-992-3836
Copyright © 2023 InvestorsHub Inc.
Replies to post #2242 on Phio Pharmaceuticals Corp (PHIO)
ash111
06/25/15 12:02 PM
#2243 RE: Inoviorulez #2242
The Other Guy
06/25/15 12:35 PM
#2250 RE: Inoviorulez #2242
Scarring anywhere from $2 billion to $5 billion macular degeneration $3 billion to $4 billion CNS disorders depends: If Rxi goes for SMA -- Spinal muscular Atrophy -- $5 billion if Rxi branches out dermatology to Chronic Wounds $15 billion - $18 billion It just depends what they choose for the Tyrosinase and collagenese compounds. -- chronic wounds falls under collagenese target if they choose it